Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jana, Zuchnická"'
Autor:
Martin Šimkovič, Peter Turcsányi, Martin Špaček, Jana Mihályová, Pavlína Ryznerová, Mária Maco, Pavel Vodárek, Dominika Écsiová, Hynek Poul, Heidi Móciková, Jana Zuchnická, Anna Panovská, Mohammad Lekaa, Martina Oršulová, Adéla Prchlíková, Lukáš Stejskal, Stanislava Mašlejová, Yvona Brychtová, Lucie Bezděková, Tomáš Papajík, Daniel Lysák, Marek Trněný, Lukáš Smolej, Michael Doubek
Publikováno v:
Annals of Hematology. 102:811-817
Autor:
Luana Schiattone, Michel van Gelder, Jana Zuchnická, Viola Maria Popov, Rosa Collado, Candida Vitale, Marta Coscia, Gloria Iacoboni, Marta Morawska, Amy Christian, Darko Antic, Vojin Vukovic, Jorge Labrador, Elżbieta Kalicińska, Marek Trněný, Anna Puiggros, Biljana Mihaljevic, Gian Matteo Rigolin, Ioannis Kotsianidis, Dimitra Chammou, Francesca Bacchiarri, Alberto Fresa, Niki Stavroyianni, Sara Galimberti, Alicia Enrico, Lydia Scarfò, David Donaldson, Jacopo Olivieri, Cheyenne Pierie, Irina Panovska, Tamar Tadmor, Maria Papaioannou, Kostas Stamatopoulos, Christos Demosthenous, Mohamed A. Yassin, Olga Kalashnikova, Fatih Demirkan, Yair Herishanu, Livio Trentin, Theodoros P. Vassilakopoulos, Volkan Karakuş, Alessandro Gozzetti, Almudena Navarro-Bailón, Maya Koren-Michowitz, Carlota Mayor-Bastida, Eric Tse, Šárka Pospíšilová, Lucrecia Yáñez, Georgios Karakatsoulis, Roberta Murru, Martin Spacek, Rocío García-Serra, Susanne R. Janssen, Robert J. Kreitman, Michael Doubek, Valerio Guarente, Eugene Nikitin, Uttam Kumar Nath, Anastasia Chatzidimitriou, Iliana Konstantinou, Arnon P. Kater, Ivana Milosevic, Annett Schiwitza, Martin Simkovic, Romain Guièze, Zhenshu Xu, Andrea Visentin, Stanislava Maslejova, Rosa Ruchlemer, Ömür Gökmen Sevindik, Gimena Dos Santos, Alberto Lopez-Garcia, Thomas Chatzikonstantinou, Francesc Bosch Albareda, Miguel Alcoceba, E. Minga, Eleftheria Hatzimichael, Elisa Albi, Lukas Smolej, Gianluca Gaidano, Rainer Claus, Antonio Cuneo, Kamel Laribi, Ramona Cassin, Michalis Iskas, Jana Kotašková, Panayiotis Panayiotidis, Tomas Papajik, Ozren Jakšić, Fatima Miras, Paolo Ghia, Maria Efstathopoulou, Luca Inchiappa, Bonnie Kho, Marcos Daniel De Deus Santos, Barbara Dreta, Constantine S. Tam, George Vrachiolias, Münci Yağcı, Blanca Espinet, B V Biderman, Stephen P. Mulligan, Zadie Davis, Svetlana Smirnova, David Oscier, Juan Marquet Palomanes, Liat Tourjeman, Sofia Chatzileontiadou, Maria Dimou, Riccardo Moia, Isabel González-Gascón y Marín, Anne Calleja, Kristina Tomic, Ilana Levy, Mehreen Ali Khan, Gerasimos Pangalis, Sean Harrop, Thérèse Aurran, Paolo Sportoletti, Dina Sameh Soliman, Shaimaa El-Ashwah, Maria K. Angelopoulou, Gianluigi Reda, Fatiha Merabet, Yandong Shen, Mark Catherwood, Luca Laurenti, Thomas Longval, Deepesh Lad
The use of novel small molecule inhibitors alone or in combination with anti-CD20 monoclonal antibodies for chronic lymphocytic leukemia (CLL) has raised a number of questions on efficacy, tolerability, long-term treatment adherence in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7a9f4cccd98d74d74691a8db760f3b4
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/98560
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/98560
Autor:
Tomas Kozak, David Belada, Yvona Brychtová, Martin Brejcha, Lukas Stejskal, Martin Spacek, Heidi Mocikova, Jana Zuchnická, Martin Simkovic, Renata Urbanova, Irena Zygulova, Michael Doubek, Eduard Cmunt, Lukas Smolej
Publikováno v:
British Journal of Haematology. 193:769-778
Therapeutic options used to be very limited for treatment-naive elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) before the introduction of chemo-immunotherapy. Because dose-reduced fludarabine-based r
Autor:
Hana Skuhrová Francová, Magdalena von Jagwitz-Biegnitz, Anna Panovská, Martin Simkovic, Jana Zuchnická, Stanislava Hrobková, Šárka Pospíšilová, Yvona Brychtová, Michael Doubek, Kamila Stránská, Jiri Mayer, Lenka Radová, Lekaa Mohammadova, Renata Urbanova, Martin Spacek, Hana Škabrahová, Karla Plevová, Lukas Smolej
Publikováno v:
Biomedical Papers, Vol 164, Iss 4, Pp 425-434 (2020)
Aims: This is a nation-wide survey of chronic lymphocytic leukemia (CLL) patients at six large hematology centers in the Czech Republic. The aim was to identify specific populations, social, and health characteristics of CLL subgroups divided accordi
Autor:
Zuzana Kubová, Mária Krčméryová, Peter Turcsányi, Jana Mihalyova, Pavel Vodárek, Heidi Mocikova, Lukas Smolej, Martin Brejcha, Jana Zuchnická, Martin Spacek, Martin Simkovic
Publikováno v:
British Journal of Haematology. 193:133-137
Most patients with chronic lymphocytic leukaemia (CLL) are nowadays diagnosed without any symptoms and do not require therapy. A prognostic score identifying patients within this large group who are at high risk of disease progression would be highly
Autor:
Hynek Poul, Šárka Pospíšilová, Eva Koriťáková, Jan Novák, Michael Doubek, Lukas Smolej, Lucie Nekvindová, Lucie Němcová, Martin Spacek, Jana Zuchnická, Daniel Lysák, Karla Plevová, Filip Vrbacký, Renata Urbanova, Tomas Papajik, Yvona Brychtová, Stanislava Mašlejová, David Starostka, Martin Brejcha, Martin Simkovic, Pavel Vodárek, Anna Panovská
Publikováno v:
Hematological Oncology. 38:509-516
Until recently, a combination of anti-CD20 antibody plus less intensive chemotherapy was a standard of care in elderly population with previously untreated chronic lymphocytic leukemia (CLL). The aim of this observational study was to retrospectively
Autor:
Tomas Jelinek, Jana Zuchnická
Publikováno v:
Blood. 135(20)
Autor:
null Anna Panovská, null Lucie NĚmcová, null Lucie Nekvindová, null Martin Špaček, null Martin Šimkovič, null Tomáš Papajík, null Martin Brejcha, null Daniel Lysák, null Jana Zuchnická, null Jan Novák, null David Starostka, null Hynek Poul, null Filip Vrbacký, null Pavel Vodárek, null Renata Urbanová, null Karla Plevová, null Šárka Pospíšilová, null Stanislava Mašlejová, null Yvona Brychtová, null Eva KoriŤáková, null Lukáš Smolej, null Michael Doubek
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::923987ac4cdea213cf6b2db9b46e13d7
https://doi.org/10.1002/hon.2744/v2/response1
https://doi.org/10.1002/hon.2744/v2/response1
Autor:
Anna, Panovská, Lucie, Němcová, Lucie, Nekvindová, Martin, Špaček, Martin, Šimkovič, Tomáš, Papajík, Martin, Brejcha, Daniel, Lysák, Jana, Zuchnická, Jan, Novák, David, Starostka, Hynek, Poul, Filip, Vrbacký, Pavel, Vodárek, Renata, Urbanová, Karla, Plevová, Šárka, Pospíšilová, Stanislava, Mašlejová, Yvona, Brychtová, Eva, Koriťáková, Lukáš, Smolej, Michael, Doubek
Publikováno v:
Hematological oncologyREFERENCES. 38(4)
Until recently, a combination of anti-CD20 antibody plus less intensive chemotherapy was a standard of care in elderly population with previously untreated chronic lymphocytic leukemia (CLL). The aim of this observational study was to retrospectively
Publikováno v:
Klinická farmakologie a farmacie. 30:8-14
Poznani funkce B-buněcneho receptoru a jeho signalizacni kaskady umožnilo vývoj molekul, ktere inhibuji jednotlive enzymy teto drahy. Ibrutinib je inhibitor Brutonovy tyrozinkinazy, ktera ma klicove postaveni v přenosu signalu tohoto receptoru. V